RVNC
|
Revance Therapeutics, Inc.
|
0.14%
|
US
|
NASDAQ
|
RVMD
|
Revolution Medicines, Inc.
|
0.14%
|
US
|
NASDAQ
|
MRVI
|
Maravai LifeSciences Holdings, Inc.
|
0.14%
|
US
|
NASDAQ
|
AMLX
|
Amylyx Pharmaceuticals, Inc.
|
0.14%
|
US
|
NASDAQ
|
DNA
|
Ginkgo Bioworks Holdings, Inc.
|
0.14%
|
US
|
NYSE
|
TWST
|
Twist Bioscience Corporation
|
0.13%
|
US
|
NASDAQ
|
RLAY
|
Relay Therapeutics, Inc.
|
0.13%
|
US
|
NASDAQ
|
RCKT
|
Rocket Pharmaceuticals, Inc.
|
0.13%
|
US
|
NASDAQ
|
TVTX
|
Travere Therapeutics, Inc.
|
0.12%
|
US
|
NASDAQ
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
0.12%
|
US
|
NASDAQ
|
MYGN
|
Myriad Genetics, Inc.
|
0.12%
|
US
|
NASDAQ
|
MNKD
|
MannKind Corporation
|
0.12%
|
US
|
NASDAQ
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
0.11%
|
US
|
NASDAQ
|
NUVL
|
Nuvalent, Inc.
|
0.11%
|
US
|
NASDAQ
|
MYOV
|
Myovant Sciences Ltd.
|
0.11%
|
US
|
NYSE
|
KYMR
|
Kymera Therapeutics, Inc.
|
0.11%
|
US
|
NASDAQ
|
KDNY
|
Chinook Therapeutics, Inc.
|
0.11%
|
US
|
NASDAQ
|
DICE
|
DICE Therapeutics, Inc.
|
0.11%
|
US
|
NASDAQ
|
ADPT
|
Adaptive Biotechnologies Corporation
|
0.11%
|
US
|
NASDAQ
|
RNA
|
Avidity Biosciences, Inc.
|
0.11%
|
US
|
NASDAQ
|